Pharmaceuticals - Community Register


List of nationally authorised medicinal products for human use

Clopidogrel Orion

Product name: Clopidogrel Orion
Active substance: Clopidogrel
Indication: Clopidogrel is indicated in adults for the prevention of atherothrombotic events in:
Patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.
Marketing Authorisation Holder: Not applicable

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
03/06/2010 Referral EMEA/H/A-29/1247 (2010)3646 of 02/06/2010